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Luminescent rhenium fac-tricarbonyl-containing complexes of androgenic oxo-
steroids 
Sam Bullocka, Andrew J. Hallettb, Lindsay P. Harding*a, Joshua J. Higginsona, Sean A.F. Pielaa, 
Simon J.A. Popeb, Craig R. Ricea 
 
Abstract 
A new route to luminescent derivatives of androgenic steroids containing a ketone group in the 3- 
or 17-position has been developed. Reaction with the fac-Re(CO)3Cl complex of 3,3’-diamino-2,2’-
bipyridine (complex 1) afforded a cyclic aminal product with different steroids. The rate of reaction 
and yield varies according to the conjugation or steric hindrance around the ketone group.  
Introduction 
The use of complexes containing luminescent transition metal ions to detect molecules of 
biological interest has gained much attention in recent years. This work has focused mainly upon 
lanthanide luminescence1 and more recently the use of d-block metal ions.2 For example, Yam and 
co-workers have prepared Pt(II), Ru(II) and Re(I) complexes for detection of biomolecules such as 
esterase3, serum albumin4 and heparin.5 Lo et al. have reported a range of Re(I)- and Ru(II)-
containing complexes which act as biomolecular probes, including biotin-transition metal 
conjugates as non-covalent probes for avidin6 and indole-appended complexes which interact with 
indole-binding proteins such as BSA and tryptophanase.7 
There are many applications for which fluorescent labelling of steroids is required, including 
immunoassays, receptor binding studies and fluorescence detection (e.g. in HPLC). Many 
fluorescent labelling reagents are in use for derivatisation of steroids; these include 1- and 9-
anthroyl nitrile8,9, nitrobenzoxadiazole10, dansyl hydrazine11, 7-alkylcoumarin derivatives12 and 
various fluorescein-containing reagents13, among others. All of these reagents utilise organic 
fluorescence which tends to possess a short lifetime, typically 0.1 – 20 ns, although this can rise to 
around 90 ns (e.g. for pyrene-containing compounds).14 In contrast to the estradiols, very few 
reactions of androgenic steroids with complexes containing luminescent metals have been 
reported; this approach offers potential advantages since metal-based luminescence often gives a 
longer emission lifetime, leading to the possibility of time-gated luminescence measurements to 
remove competing signals from background autofluorescence in biological systems. However, it is 
frequently the case in such systems that multi-step synthetic modification of the steroid backbone 
is required prior to coordination of the metal ion. 
We report herein a new route to simple, one-step functionalisation of dihydrotestosterone, a 
biologically important androgenic steroid, with a rhenium fac-tricarbonyl bipyridyl complex 
containing a diamino unit remote from the metal centre. The attempted reactions of testosterone 
and androsterone are also presented. Some examples of rhenium-containing androgen derivatives 
have been reported; Wüst et al prepared such complexes by funtionalising testosterone at the 7-
position with thiol-containing ligands capable of coordinating an oxorhenium centre.15 Jaouen and 
coworkers have synthesised a range of CpRe(CO)3-substituted complexes of cholest-4-en-3-one16, 
and latterly of testosterone and DHT.17  
Transition metal complexes containing ligands with a 3,3’-diamino-2,2’-bipyridyl core have been 
shown previously to react readily with ketones18 and aldehydes19 to form seven-membered cyclic 
aminal products and therefore this chemistry was utilised in this study. 
The three steroids used in this work (Fig. 1a) are all members of the androstane sub-class whose 
general structure is shown in Fig. 1b; the androstanes are characterised by the methyl substituents 
at positions 10 and 13 of the tetracyclic steroid backbone.20 These three steroids vary in the 
degree of conjugation or steric hindrance around the ketone moieties; their reactivities may be 
expected to differ significantly for this reason. 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1: a) Structures of dihydrotestosterone, testosterone and androsterone; b) the general structure of 
androstanes, showing the IUPAC steroid numbering convention20 
 
Results & Discussion 
Synthesis of complex 1 
3,3’-Diamino-2,2’-bipyridine was prepared from 3-amino-2-chloropyridine according to literature 
methods.21 The rhenium complex of 3,3’-diamino-2,2’-bipyridine (1) was prepared by reaction of 
the ligand with rhenium pentacarbonyl chloride in dichloromethane under reflux (Scheme 1). As 
expected the 1H and 13C NMR analysis was consistent with the formation of the rhenium complex; 
in addition the ESI-MS gave an ion at m/z 457.0 (corresponding to [M-Cl]+) whose composition was 
confirmed by accurate mass measurements. 
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Scheme 1: Synthesis of the rhenium complex of 3,3’-diamino-2,2’-bipyridine, 1 
 
Reaction of 1 with dihydrotestosterone (DHT) 
The reaction of 1 with DHT was monitored via thin layer chromatography until the rhenium-
containing starting material had been consumed. A yellow solid (1-DHT) was produced following 
initial purification of the crude product by passage through a plug of alumina (2% MeOH in DCM). 
The 1H NMR spectrum of the resultant solid (CD3CN) showed a complex series of highly coupled 
signals (Fig 2).  
 
 
Fig. 2: 1H NMR spectrum of the crude 1-DHT product showing an expansion of the aromatic region (inset) 
 
Close examination of the aromatic region reveals the presence of four sets of signals from the 
bipyridyl moiety indicating that there are isomeric products present in solution.  
The ESI-mass spectrum of the product (MeCN) gave a predominant ion at m/z 787.2 
corresponding to ([(1-DHT)+Na]+); this composition was confirmed by accurate mass 
measurements. In addition, the measured isotope pattern of the ion at m/z value 787.2 closely 
matched the calculated pattern for C32H38N4O4Re1Cl1Na1 (Fig. 3). 
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Fig. 3: Measured (top) and calculated (bottom) isotope patterns of C32H38N4O4Re1Cl1Na1 
 
This evidence clearly shows that DHT has reacted with the rhenium complex; however, the NMR 
analysis is consistent with the formation of isomeric products. Furthermore, thin layer 
chromatography shows two products with very similar retention factors. Careful column 
chromatography produced small amounts of the purified materials which upon analysis gave much 
simplified NMR spectra (Fig. 4). 
 
 
Fig. 4: Selected regions of the 1H NMR spectra of the crude material (top), the early eluting fraction (centre), 
the late eluting fraction (bottom) 
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Solid-state analysis 
Crystallisation was achieved on one of the fractions by slow diffusion of diisopropyl ether into an 
acetonitrile solution of the purified product. X-ray analysis showed that in the solid state the 
rhenium centre adopts an octahedral geometry and is coordinated by two pyridyl nitrogen atoms in 
its equatorial positions (Fig. 5a). Two carbonyl ligands fill the other two equatorial sites and the 
axial positions are occupied by another carbonyl ligand and a chloride ion (Re-N distances 
2.164(3) and 2.161(3) Å; Re-C distances 1.906(5) – 1.925(5) Å; Re-Cl distance 2.4904(11) Å). 
The amine groups of complex 1 have reacted with the ketone group on position 3 of the steroid to 
form a 7-membered aminal ring; the steroid is positioned in a trans-oid geometry relative to the 
chloride on the rhenium centre. The structure is highly unsymmetrical, with the steroid moiety 
leaning significantly towards one pyridyl ring (Fig. 5b). 
 
 
Fig. 5: The single crystal X-ray structure of 1-DHT (a) as a displacement ellipsoid plot drawn at the 50% 
probability level; (b) showing the inequivalence of the bipyridyl rings 
 
Examination of the intermolecular packing (Fig. 6) shows that the chloride ion from each molecule 
forms a hydrogen bond to the hydroxyl group in the 17-position of DHT (Cl-H distance 2.414 Å). 
 
Fig. 6: The single crystal X-ray structure of 1-DHT showing the intermolecular packing 
 
Solution-state analysis 
Close examination of the solid state structure demonstrates why the 1H NMR spectrum is so 
complex. Firstly, the steroid can react with the complex by approaching it in two different ways, 
giving the isomers i and ii (Fig. 7) which can be separated by chromatography and result in 
simplified 1H NMR spectra. Secondly, due to the non-planarity of the steroid each of the pyridyl 
rings is not equivalent to the other (Fig 5b) resulting in the doubling-up of the aromatic signals in 
the 1H and 13C NMR spectra. It is therefore clear that the two geometric isomers can be separated 
by column chromatography giving a pure complex which contains inequivalent bipyridyl 
heterocyclic rings. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 7: The possible isomers of 1-DHT 
 
It is worth noting that it is entirely feasible that there are conformers of i and ii generated by the 
inability of the aminal ring to invert (iv and iii respectively, Fig. 7). However, this would give rise to 
another set of signals which we do not observe. It is therefore likely that in solution the barrier to 
inversion is sufficiently low that it is not observed on the NMR timescale at room temperature. To 
confirm this, cyclohexanone was reacted with 1 to give a similar aminal species, but one which 
contains a highly symmetrical cyclohexyl unit. If the aminal interconversion were slow, on the NMR 
timescale, this would give rise to two different species. However, analysis of the crude material 
demonstrated only one species was formed (Figs S7 and S8, ESI). 
Characterisation of the product by NMR 
The purified product was characterised fully using 1D and 2D NMR techniques (including COSY, 
HSQC, HMBC, TOCSY and NOESY); spectra were acquired in DMSO-d6 to aid solubility and thus 
facilitate acquisition of 13C-detected experiments.  
[i] [ii] 
[iii] [iv] 
Carbons 1, 2, 4 and 5 (see Fig. 1) exhibit a marked upfield shift relative to the starting material, 
which confirms that derivatisation of the steroid has taken place at position 3 (Fig. 8). The signal 
from C3 itself moves from 210.97 ppm in the underivatised steroid to 67.52 ppm in the product 
which is typical for a quaternary carbon bonded to nitrogen. In addition, the HMBC spectrum shows 
2JH,C couplings from the NH groups of the aminal ring to C3 of the steroid (Fig. S4, ESI).  
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 8: Selected regions of the 13C{1H} spectra (DMSO-d6) of DHT (top) and 1-DHT (bottom) 
 
As expected due to their inequivalence, two sets of signals are observed for the pyridyl protons as 
shown in the HSQC spectrum (Fig. 9). The remaining, uncorrelated carbon signals are from the 
quaternary carbons (2 and 3) in the pyridyl rings. 
 
 
Fig. 9: Selected region of the 1H-13C HSQC spectrum (DMSO-d6) of 1-DHT  
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DFT and luminescence studies 
DFT calculations on a structurally simplified bis-aminal analogue (i.e. assuming the condensation 
of the diamine with acetone) were undertaken to explore the nature of the frontier orbitals. 
Unexpectedly the optimised lowest energy conformation of the complex predicts an out of 
equatorial plane distortion (20.04°) for the bpy ligand, which is not as pronounced in the crystal 
structure of 1-DHT. The HOMO (E = -5.52 eV) and HOMO-1 (E = -5.61 eV) are close enough in 
energy (ΔE < 0.2 eV) to be considered isoenergetic and mainly situated on Re and Cl, whilst the 
LUMO (E = -2.37 eV) is sufficiently different in energy to be considered independent and located 
primarily on the bpy ligand.  
The pictorial representations and relative distributions of the frontier orbitals are shown in Fig. 10 
and Table 1, respectively. The mixed metal/halide character is consistent with previous 
descriptions for complexes of this type22 and suggests an excited state delocalised positive hole. 
The results suggest the lowest energy absorption should be reported as a HOMO* (bpy), in turn 
suggesting that significant MLCT and LLCT character be predicted for the lowest energy excited 
state.  
 
Fig 10: Representations of the calculated HOMO and LUMO 
 
 
 
 
 
 HOMO-1 HOMO LUMO 
Re 38.2 41.6 3.6 
Cl 36.9 38.1 2.1 
CO (eq 1) 3.1 3.7 1.0 
CO (eq 2) 3.1 3.7 1.0 
CO (ax) 8.8 9.5 0.9 
bpy 10.9 3.4 91.4 
 
Table 1: Percentage distribution of HOMO-1, HOMO and LUMO over complex 
 
The absorption spectra for the complexes show two main features with ligand-centred transitions 
dominating < 300 nm and broad visible absorption at 330-450 nm associated with LLCT/MLCT 
character (cf. DFT); the spectrum of 1-DHT showed a definitive red-shift in the absorption 
maximum of this band to ca. 410 nm.  
The room temperature luminescence properties of the free ligand (3,3’-diamino-2,2’-bipyridine), 
complexes 1 and 1-DHT were assessed in two aerated solvents (MeOH, and CHCl3). The free 
ligand gave emission spectra with a fluorescence peak at 436 nm (MeOH,  = 1.4 ns) or 478 nm 
(CHCl3,  = 1.7 ns). In methanol the diamino complex 1 (ex = 335 nm) was emissive at 443 nm, 
whereas in chloroform only one band at 581 nm was evident. The lifetime in MeOH was 2.7 ns, 
and this was attributed to a metal-perturbed ligand-centred emission. The long wavelength band 
observed in CHCl3 must be attributed to the MLCT/LLCT character, as discussed in the context of 
the DFT results, and the lifetime associated with this emission was longer-lived (ex = 295 nm) at 
119 ns. For comparison, solvent-sensitive photophysical properties are obtained for 
[ReCl(CO)3(bpy)] where lifetimes were 18.8 ns (MeOH) and 39.8 ns (CHCl3); a value of 39 ns has 
also been reported in mthf.23 Formation of the bis-aminal 1-DHT species resulted in a 
bathochromic shift of the lowest energy broad absorption band to ca. 440 nm and irradiation of this 
peak (ex = 435 nm) gave emission bands at 533 (MeOH) and 564 nm (CHCl3), each attributed to 
the MLCT/LLCT character, as described above. However, the lifetimes were very short (3.5 ns in 
CHCl3; < 1ns in MeOH) for this species, suggesting that the presence of the bis-aminal 
functionality may provide an effective quenching pathway for the excited state. Interestingly, it was 
possible to solubilise complexes 1 and 1-DHT in buffered (MOPS) aqueous solution. The 
differences in absorption wavelength allowed the selective and differential irradiation (ex = 435 
nm) of 1-DHT (Fig. 11), indicating the potential of the complex in a sensing or biomarker capacity. 
 
 
 
 
 
 
 
 
  
Fig. 11: Emission spectra for complex 1 (black) and 1-DHT (red) recorded in MOPS buffer (ex = 435 nm) 
 
Reaction of 1 with other oxo-steroids 
Reaction of equimolar amounts of 1 and testosterone (T) in CD3CN proceeded significantly more 
slowly than the analogous DHT reaction; after heating for 8 hours analysis of the reaction mixture 
by 1H NMR spectrometry showed that approximately 60% conversion to 1-T had been achieved. In 
a similar fashion reaction of equimolar amounts of 1 and androsterone (ADT) in CD3CN proceeded 
very slowly; again after heating for 8 hours analysis of the reaction mixture by 1H NMR 
spectrometry showed that only approximately 30% conversion to 1-ADT had been achieved. 
The difference in rate and yield of these compounds compared to DHT is due to the conjugated 
ketone of T and the close proximity of a methyl group in ADT which reduce the rate of reaction due 
to electronic and steric effects respectively. 
Conclusion 
A new route to one-step derivatisation of oxo-steroids has been developed. The Re(I)-containing 
diamine complex reacts with DHT to give two isomers which can be separated and examined in 
the solution and solid states. Furthermore, reaction with DHT bathochromically shifts the visible 
absorption profile and results in a luminescent Re-based product emitting in the visible region. 
Experimental 
General 
All photophysical data were obtained on a JobinYvon-Horiba Fluorolog spectrometer fitted with a 
JY TBX picosecond photodetection module. Lifetimes were obtained using the provided 
deconvolution software DAS6. Electrospray ionisation mass spectra were recorded from 10-3 M 
solutions on a Bruker MicrOTOF-q instrument.  
Synthesis of complex 1 
3,3’-Diamino-2,2’-bipyridine was prepared from 3-amino-2-chloropyridine according to literature 
methods.21  
To 3,3’-diamino-2,2’-bipyridine (0.10 g, 0.54 mmol) in dichloromethane (25 mL) was added 
rhenium pentacarbonyl chloride (0.19 g, 0.54 mmol) and the reaction was heated under reflux in 
the dark for 18 hours. The reaction was cooled and filtered in vacuo; the pale yellow product 1 was 
washed with Et2O and dried. (128.8 mg, 48%) 
1H NMR = [400 MHz, DMSO-d6]  8.37 (dd, J = 5.0, 1.3, 2H, py), 7.58 (dd, J = 8. 5, 1.3, 2H, py), 
7.39 (dd, J = 8.5/5.0 Hz, 2H, py), 6.20 (s, broad, 4H, NH2) 
13C NMR = [400 MHz, DMSO-d6] 199.10 (C=O), 191.99 (C=O), 144.00 (py quaternary), 142.34 
(py CH), 139.93 (py quaternary), 128.29 (py CH), 125.81 (py CH) 
ESI-MS found m/z 457.0 [M-Cl]+, HR-ESI-MS found 457.0325, C13H10N4O3Re1 requires 457.0305. 
UV-vis (CHCl3): λmax (ε / dm3 mol-1 cm-1) 274(3900), 380(8200) nm. 
Synthesis of derivatives of complex 1 
Dihydrotestosterone  
Dihydrotestosterone (3.04 mg, 0.01 mmol) and 1 (5.04 mg, 0.01 mmol) were dissolved in 
acetonitrile (1 mL). A few grains of camphorsulfonic acid were added and the solution was heated 
at 60°C for two hours. The product was purified via column chromatography (Al2O3, 2% MeOH in 
DCM). The yield of the two purified fractions was 4.97 mg, 62%.  
NMR – see the text for discussion of the NMR spectra. Characterisation of the purified product was 
carried out in DMSO-d6 on a Bruker Avance 500 MHz spectrometer using Bruker’s standard pulse 
programs, with increased numbers of scans where necessary.  
ESI-MS found m/z 787.2 [M+Na]+, HR-ESI-MS found 787.2011, C32H38N4O4Re1Cl1Na1 requires 
787.2031. IR (ATR) /cm-1: 3308 (w, OH), 2931 (m, CH), 2847 (m, CH), 2014 (s, CO), 1900 (s, 
CO), 1879 (s, CO). UV-vis (MeCN): λmax (ε / dm3 mol-1 cm-1) 290(12600), 411(19000) nm. 
Testosterone and androsterone 
1-T and 1-ADT were prepared by dissolving ca. 2 mg of complex 1 with 1 eq. of steroid and a few 
grains of camphorsulfonic acid in 0.65 mL CD3CN and heating to 60C for 8 hours. The reactions 
were monitored using 1H NMR spectrometry. 
Cyclohexanone 
Complex 1 (20 mg, 0.04 mmol) was dissolved in dichloromethane (10 mL). Cyclohexanone (10 L, 
2.5 eq.) and a few grains of camphorsulfonic acid were added and the solution was stirred at room 
temperature for 2 hours. The resulting precipitate was filtered under vacuum and washed with 
dichloromethane (2 x 2mL), giving a bright yellow solid (15 mg, 65%). 
1H NMR = [500 MHz, DMSO-d6] 8.42 (dd, J = 5.02/1.32, 2H, py), 7.66 (dd, J = 8.50/1.32, 2H, py), 
7.30 (dd, J = 8.48/5.06 Hz, 2H, py), 7.21 (s, broad, 2H, NH), 1.73 (m, broad, 4H, CH2), 1.62 (m, 
broad, 2H, CH2), 1.42 (m, broad, 4H, CH2) 
13C NMR = [500 MHz, DMSO-d6]  199.15 (C=O), 192.06(C=O), 145.12 (py quaternary), 143.92 
(py CH), 141.41 (py quaternary), 129.76 (py CH), 125.40 (py CH), 67.50 (cyclohexyl quaternary), 
35.71, 34.35, 25.30, 21.70 (cyclohexyl CH2s)  
ESI-MS found m/z 537.1 [M-Cl]+, HR-ESI-MS found 537.0926, C19H18N4O3Re1 requires 537.0931. 
Crystallographic data 
Single crystal X-ray diffraction data were collected on a Bruker Apex Duo diffractometer equipped 
with a graphite monochromated Mo(K) radiation source and a cold stream of N2 gas.  
Crystal data for {1-DHT·DIPE} (C19H26Cl0.5N2O2.5Re0.5): M = 866.49; Monoclinic, P21, a = 
12.8902(7), b = 10.9298(5), c = 13.7766(7) Å,  = 109.1860(10)°; V = 1833.14(16) Å3, Z = 2; ρcalc = 
1.570 Mg m-3, F(000) = 880; dimensions 0.18×0.10×0.03 mm; μ(MoKα) = 0.71073 mm-1, T = 150 (2) 
K. A total of 28751 reflections were measured in the range 1.57 ≤ θ ≤ 33.25 ˚ (hkl range indices: -
19≤h≤17, -13≤k≤16, -21≤l≤21), 13094 unique reflections (Rint = 0.0472). The structure was refined 
on F2 to Rw = 0.0630, R = 0.0356 (10555 reflections with I > 2σ(I)) and GOF = 0.918 on F2 for 449 
refined parameters, 16 restraints. The diisopropyl ether molecule within the unit cell showed some 
disorder and was constrained using SIMU and DELU commands in the refinement. Largest peak 
and hole 1.271 and -0.973 eÅ-3. CCDC 887418.  
DFT calculations 
DFT calculations were performed on the Gaussian 03 program.24 Geometry optimisations were 
carried out without constraints using the B3PW91 functional. The LANL2DZ basis set was used for 
the Re centre, and was invoked with pseudo-potentials for the core electrons, a 6-31G(d,p) basis 
set for all coordinating (and oxygen of CO ) atoms with a 6-31G basis set for all remaining atoms. 
All optimisations were followed by frequency calculations to ascertain the nature of the stationary 
point (minimum or saddle point). 
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